ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-27
DOI
10.1186/s13046-019-1506-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
- (2019) Nadia Habel et al. BMC CANCER
- SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma
- (2019) Ilka Isfort et al. CLINICAL CANCER RESEARCH
- Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
- (2019) Patrizia Nanni et al. Scientific Reports
- Connective tissue growth factor stimulates osteosarcoma cell migration and induces osteosarcoma metastasis by upregulating VCAM-1 expression
- (2018) Chun-Han Hou et al. BIOCHEMICAL PHARMACOLOGY
- Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines
- (2018) Maria Ferraiuolo et al. CANCER LETTERS
- Regulation of the Hippo pathway in cancer biology
- (2018) Sungho Moon et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Patient-derived xenograft models in musculoskeletal malignancies
- (2018) Wan Lu et al. Journal of Translational Medicine
- Hippo Signaling in the Immune System
- (2018) Yuchao Zhang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Pazopanib in relapsed osteosarcoma patients: report on 15 cases
- (2018) Alessandra Longhi et al. ACTA ONCOLOGICA
- Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)
- (2018) Stefano Ferrari et al. TUMORI
- Generation of patient‐derived tumor xenografts from percutaneous tumor biopsies in children with bone sarcomas
- (2018) Nino Rainusso et al. PEDIATRIC BLOOD & CANCER
- Orthotopic patient-derived xenografts of paediatric solid tumours
- (2017) Elizabeth Stewart et al. NATURE
- Pazopanib for second recurrence of osteosarcoma in pediatric patients
- (2017) Katsutsugu Umeda et al. PEDIATRICS INTERNATIONAL
- The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
- (2017) Y-H. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Metastatic osteosarcoma: a challenging multidisciplinary treatment
- (2016) Cristina Meazza et al. Expert Review of Anticancer Therapy
- Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
- (2016) Corinne Bouvier et al. Oncotarget
- Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
- (2015) Kyle R. Duchman et al. Cancer Epidemiology
- Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)
- (2015) JUN LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
- (2015) Yangbo Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells
- (2015) Upal Basu-Roy et al. Nature Communications
- Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
- (2015) Yusuke Oku et al. FEBS Open Bio
- The mammalian Hippo pathway: regulation and function of YAP1 and TAZ
- (2014) Manami Kodaka et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth
- (2014) Boon Chuan Low et al. FEBS LETTERS
- The Hippo pathway in chemotherapeutic drug resistance
- (2014) Yulei Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway
- (2014) Chun-Han Hou et al. Molecular Cancer
- YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
- (2014) Yan Xia et al. PLoS One
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- The CCN Family Proteins: Modulators of Bone Development and Novel Targets in Bone-Associated Tumors
- (2014) Po-Chun Chen et al. Biomed Research International
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
- (2013) Fernando Calvo et al. NATURE CELL BIOLOGY
- CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity
- (2013) C Zucchini et al. ONCOGENE
- Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression
- (2013) L H Chan et al. ONCOGENE
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1
- (2012) Stefano Ferrari et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Regulation of Adhesion Complex Turnover by ROCK1 and ROCK2
- (2012) Frances E. Lock et al. PLoS One
- Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage
- (2011) Guang Jian Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice
- (2011) Adam A Sabile et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- YAP is a candidate oncogene for esophageal squamous cell carcinoma
- (2010) Tomoki Muramatsu et al. CARCINOGENESIS
- Prognostic Value of CCN3 in Osteosarcoma
- (2008) B. Perbal et al. CLINICAL CANCER RESEARCH
- Therapy for Osteosarcoma
- (2008) Alexander J Chou et al. PEDIATRIC DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now